Brian G. Atwood - Mar 25, 2024 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Executive Officer, Director
Signature
/s/ Charles Carter, attorney-in-fact
Stock symbol
CERO
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 09:24 PM
Previous filing
Feb 16, 2024
Next filing
Jul 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +1.32M $0.00 1.32M Mar 25, 2024 Common Stock 1.32M $1.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest as follows: 732,198 shares are immediately vested and exercisable, and the remainder shall vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.